Airsculpt Technologies Inc $AIRS

Health Care

$1.25
-0.03 (-2.34%)
As of Oct 22, 2026, 5:46 PM EDT
Price history
Loading chart…

Airsculpt Technologies Inc (AIRS) is trading down at $1.25 (-2.34%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: October 29, 2021 · $11.00 offering · NASDAQ · View IPO details →

Airsculpt Technologies Inc revenue & net income history (FY2019–FY2025)

RevenueNet incomeNet margin (right axis, %)
$195.9M$90.6M−$14.7MFY2019 revenue: $41.2MFY2019 net income: −$2.21M · Net margin −5.4%'19FY2020 revenue: $62.8MFY2020 net income: $7.58M · Net margin 12.1%'20FY2021 revenue: $133.3MFY2021 net income: $10.6M · Net margin 7.9%'21FY2022 revenue: $168.8MFY2022 net income: −$14.7M · Net margin −8.7%'22FY2023 revenue: $195.9MFY2023 net income: −$4.24M · Net margin −2.2%'23FY2024 revenue: $180.3MFY2024 net income: −$8.02M · Net margin −4.4%'24FY2025 revenue: $151.8MFY2025 net income: −$11.7M · Net margin −7.7%'250%10%20%30%FY2019 net margin: −5.4% (off the scale, which stops at −2.2%)FY2020 net margin: 12.1%FY2021 net margin: 7.9%FY2022 net margin: −8.7% (off the scale, which stops at −2.2%)FY2023 net margin: −2.2%FY2024 net margin: −4.4% (off the scale, which stops at −2.2%)FY2025 net margin: −7.7% (off the scale, which stops at −2.2%)
Airsculpt Technologies Inc annual financial statements
FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$41.2M$62.8M$133.3M$168.8M$195.9M$180.3M$151.8M
Growth (year over year)—+52.2%+112.4%+26.6%+16.1%−7.9%−15.8%
Gross profit$25.7M$39.3M$88.8M$106.0M$122.1M$109.2M$90.1M
Gross margin62.4%62.6%66.6%62.8%62.3%60.5%59.4%
Operating income$663.0K$10.0M$15.8M−$4.54M$9.72M−$1.58M−$11.6M
Operating margin1.6%16.0%11.8%−2.7%5.0%−0.9%−7.6%
Net income−$2.21M$7.58M$10.6M−$14.7M−$4.24M−$8.02M−$11.7M
Net margin−5.4%12.1%7.9%−8.7%−2.2%−4.4%−7.7%
EPS (diluted)——−$0.01−$0.26−$0.08−$0.14−$0.19
Balance sheet
Cash and equivalents$5.13M$10.4M$25.3M$9.62M$10.3M$8.23M$8.45M
Total assets—$179.6M$200.6M$200.8M$204.0M$212.8M$187.3M
Total liabilities—$55.9M$117.0M$130.0M$120.0M$134.6M$99.6M
Long-term debt—$32.1M$81.8M$81.4M$69.5M$65.5M$50.6M
Shareholders' equity——$83.5M$70.8M$82.7M$78.2M$87.7M
Cash flow
Operating cash flow$4.94M$14.0M$26.6M$24.4M$24.0M$11.3M$3.10M
Capital expenditure$4.44M$3.69M$7.12M$12.9M$9.92M$14.0M$2.40M
Free cash flow$499.0K$10.3M$19.5M$11.5M$14.0M−$2.66M$692.0K
Dividends paid—$0$0$23.2M$385.0K$252.0K$0

From Airsculpt Technologies Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Airsculpt Technologies Inc

Headquarters
Tampa, Florida From SEC filings, Oct 2026

Recent News

No recent news mentioning Airsculpt Technologies Inc in our feed yet.

More Health Care stocks

Browse all companies →